Richard L. Sherman
Mr. Sherman has
been a Venture Partner with SCP focusing on the life sciences area. Prior to
joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel
of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and
managing officer (1992-2001) of QED Technologies, Inc., a life science business
consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in
New York.
Mr. Sherman has served on the Board of Directors of CytoMed, Inc., IBAH, Inc.,
Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta
Pharmaceuticals. He is Chairman of the Board of Biophage, Inc., and is a board
member of the Sbarro Research Organization. He also serves as Secretary and
General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of
Goodsill Anderson Quinn & Stifel, and is a
principal in CIP Capital, L.P.
He is on the Technology Advisory Board for The Children's Hospital of
Philadelphia and is a member of the Advisory Board of the University of Hawaii
Medical School.
Mr. Sherman graduated magna cum laude from the University of Nebraska (1968),
where he was elected to Phi Beta Kappa. He received his J.D. from New York
University School of Law in 1971 as a Root-Tilden Scholar.
Home |
Our Philosophy | Our Investment Strategy and Focus Areas |
The Team
Our Portfolio |
News
| Contact Us |
LP Login |
Submit a Business Plan
© 2006 SCP Partners. All Rights Reserved.
|
|


Richard L. Sherman

Dr. Abraham Ludomirski
Wayne B. Weisman
Jeff Dykan
Winston J. Churchill
Gerri Henwood
|